GTx Incorporated

From Wikipedia, the free encyclopedia
Jump to: navigation, search
GTx, Inc.
Type Public
Traded as NASDAQGTXI
Industry Pharmaceuticals
Founded September 24, 1997
Headquarters Memphis, Tennessee, United States
Products Toremifene, Ostarine, Andarine
Website GTxInc.com

GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.[1] Its major product to date is toremifene, and drugs in development include Ostarine and GTx-758. The company has undertaken partnerships with other biotechnology companies such as Merck[2] in the development of drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes.

References[edit]